Top Markets
#1 TENDIES TENDIES +47.26%
#2 Cash Cat Cash Cat +32.66%
#3 Threshold Network Threshold Network +20.34%
#4 OSK OSK +15.77%
#5 Asteroid Shiba Asteroid Shiba +12.66%
#6 Ape and Pepe Ape and Pepe +12.62%
#7 Magma Finance Magma Finance +12.59%
#8 龙虾 (Lobster) 龙虾 (Lobster) +12.14%
#9 Kite Kite +10.97%
#10 MarsCoin MarsCoin +10.48%
Coin of the day
TENDIES TENDIES
Instellingen
Taal
DUTCH
Valuta
USD
Thema
AIM Vaccine Co., Ltd. AIM Vaccine Co., Ltd.

AIM Vaccine Co., Ltd.

6660
Rang in aandelen #16674
Operating within the People's Republic of China, AIM Vaccine Co., Ltd.... Operating within the People's Republic of China, AIM Vaccine Co., Ltd. specializes in the entire lifecycle of human vaccine products, encompassing their discovery, production, and market introduction. Among its current developments, the company is advancing Bivalent Delta-Omicron BA.5 mRNA and Monovalent Omicron BA.5 mRNA vaccine candidates for COVID-19, both currently undergoing Phase III clinical trials. Its comprehensive portfolio also features vaccines targeting a range of other conditions, such as an EV71-CA16 Bivalent vaccine for Hand, Foot, and Mouth Disease (HFMD), and both Conjugate and Polysaccharide versions for pneumococcal disease. Further offerings include a Hexavalent group B Streptococcus Polysaccharide Conjugate Vaccine, various Diphtheria, Tetanus, and Pertussis (DTP) formulations (including DTP combined with Haemophilus Influenzae type B, acellular pertussis, and absorbed tetanus), a Haemophilus Influenzae Type B (Hib) vaccine, and both traditional freeze-dried and innovative mRNA human rabies vaccines. Beyond these, AIM Vaccine is actively developing several other vaccines, including 2- and 3-valent Human Papillomavirus (HPV) vaccines, a Tetravalent Meningococcal Conjugate vaccine, a Tetravalent Influenza vaccine, mRNA-based vaccines for Shingles/Herpes Zoster and Respiratory Syncytial Virus (RSV), a live attenuated parotitis vaccine, and an ACYW135 meningococcal polysaccharide vaccine. Established in 2011 and headquartered in Beijing, PRC, the company adopted its current name, AIM Vaccine Co., Ltd., in September 2020, having previously operated as Beijing AIM Biological Vaccine Technology Group Co., Ltd.
Aandeelprijs
$0.23346537
Marktkapitalisatie
$285.87M
Verandering (1 dag)
6.41%
Verandering (1 jaar)
-63.91%
Land
CN
Handel AIM Vaccine Co., Ltd. (6660)

Categorie

Healthcare
Koersgeschiedenis voor AIM Vaccine Co., Ltd. (6660)
Hoogste slotkoers: $0.23 op 2026-09-01

Laagste slotkoers: $2.84 op 2022-10-01
Koersgeschiedenis van AIM Vaccine Co., Ltd. van 2022 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -13.76%
2025 -48.14%
2024 -16.05%
2023 -68.54%
2022 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.15 36.70%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.33%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $153.87 536.09%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.21 -10.03%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $755.10 7.83%
CH